BiotechTube

HPN-100 + HPN-100 or Placebo + Placebo + Moxifloxacin + HPN-100 + HPN-100

Phase 1Completed
1 views this week 0 watching💤 Quiet
Interest: 29/100
29
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Drug Toxicity

Conditions

Drug Toxicity

Trial Timeline

May 1, 2010 → Sep 1, 2010

NCT ID
NCT01135680

About HPN-100 + HPN-100 or Placebo + Placebo + Moxifloxacin + HPN-100 + HPN-100

HPN-100 + HPN-100 or Placebo + Placebo + Moxifloxacin + HPN-100 + HPN-100 is a phase 1 stage product being developed by Amgen for Drug Toxicity. The current trial status is completed. This product is registered under clinical trial identifier NCT01135680. Target conditions include Drug Toxicity.

What happened to similar drugs?

8 of 15 similar drugs in Drug Toxicity were approved

Approved (8) Terminated (3) Active (5)
✅CefiderocolShionogiApproved
✅OnabotulinumtoxinA 145 UNT [Botox]AbbVieApproved
✅Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mLNovartisApproved
✅Oseltamivir + WarfarinRocheApproved
✅Rivaroxaban 20mg + Sotorasib 960mgAmgenApproved
✅Polyene phosphatidylcholine injection 930 mg QD + Magnesium Isoglycyrrhizinate injection 200 mg QDHaisco Pharmaceutical GroupApproved
✅AZILECT® + PlaceboLundbeckApproved

Hype Score Breakdown

Clinical
6
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT01135680Phase 1Completed

Competing Products

20 competing products in Drug Toxicity

See all competitors
ProductCompanyStageHype Score
ORIN1001Fosun PharmaPhase 1/2
32
GP404141 + NplateGEROPHARMPhase 3
34
Crestor 10mg(Rosuvastatin 10mg), Glucodown OR SR 750mg(Metformin SR 750mg)YuhanPhase 1
29
Tolbutamide + Midazolam + PexidartinibDaiichi SankyoPhase 1
29
DS-8500a + RosuvastatinDaiichi SankyoPhase 1
29
DS-1040b + ClopidogrelDaiichi SankyoPhase 1
29
EC905 + verapamilAstellas PharmaPhase 1
29
rosuvastatin + fidaxomicinAstellas PharmaPhase 1
29
enzalutamide + rifampinAstellas PharmaPhase 1
29
ASP3652 + Gemfibrozil + RepaglinideAstellas PharmaPhase 1
29
CefiderocolShionogiApproved
50
Placebo + Active Comparator #1 + Active Comparator #2 + Active Comparator #3 + Lorcaserin Dose #1 + Lorcaserin Dose #2 + Lorcaserin Dose #3EisaiPhase 1
29
Istradefylline + Phentermine 45 mgKyowa KirinPhase 1
29
Lasmiditan + Alprazolam + PlaceboEli LillyPhase 1
29
Nasal Glucagon (NG) + Glucagon IMEli LillyPhase 3
40
napabucasin + cytochrome P450 (CYP450) probe drugs or BCRP transporter substrateSumitomo PharmaPhase 1
29
Norgestimate; Ethinyl Estradiol; Folic acidJohnson & JohnsonPhase 1
29
Norgestimate; Ethinyl Estradiol; Folic acidJohnson & JohnsonPhase 1
29
Loperamide / Red Grapefruit Juice + Loperamide/ White Grapefruit Juice + Loperamide / Pink Grapefruit JuiceJohnson & JohnsonPhase 1
29
HR17031 injection + insulin glargineJiangsu Hengrui MedicinePhase 3
40